The trajectory of Sildenafil presents a complex picture for those considering investment. While the initial launch generated significant profits, the expiration of its exclusive rights opened the floodgates to cheaper https://companyspage.com/story6655093/sildenafil-and-the-pharmaceutical-industry-a-risky-opportunity